R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL
Clinical trial NCT04992377 · UNKNOWN
Trial details
- NCT number
- NCT04992377
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2024-08-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.